FSSAI takes action against six nutraceutical manufacturers for food safety violations
Read more
Business Standard
business-standard.com

FSSAI takes action against six nutraceutical manufacturers for food safety violations

The Food Safety and Standards Authority of India (FSSAI) announced on Monday that it has taken regulatory measures against nutraceutical manufacturers, including license suspensions, due to serious violations of food safety rules.

FSSAI defines nutraceuticals as a category of products consisting of extracts, isolated, and purified chemical compounds that provide physiological benefits and contribute to maintaining health. These products are made from food ingredients and offer targeted, medicine-like health benefits beyond daily nutrition, and are primarily regulated by FSSAI.

Although part of the industry advocates for stricter regulation of nutraceuticals due to their widespread use, the food sector insists on lighter oversight. Recently, the regulator has intensified inspections of manufacturing facilities, especially in the nutraceutical sector. It identified several manufacturers, products, and violations in a post on Instagram, and also published photos of unhygienic conditions at production sites.

The six companies subjected to FSSAI action include Airen Herbals, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare, and Vedant Remedies.

Violations found at specific manufacturers

Violations were found in two products from Airen Herbals. The syrup 'Lycowey Syrup' contained thiamine, vitamin E acetate, copper, selenium, and zinc in concentrations exceeding the established daily recommended intake (RDA) per serving. The product 'Maxford Pain Relief' featured unauthorized claims of knee pain relief and images related to knee pain. Furthermore, the thiamine level exceeded the established RDA per serving, and the declaration of the botanical ingredient did not comply with nutraceutical standards.

The regulator also discovered expired raw materials stored at Aquabliss Lifesciences' facility, along with poor sanitary and hygienic conditions.

In Raskam Healthcare's products, the use of the unapproved ingredient 'Shilajit' was noted, and non-compliance with requirements for maintaining necessary documentation and records was identified.

At Supercure Biotech, the capsules 'Gemkolin 9G softgel' contained 100 mcg of biotin, which exceeds the maximum permissible RDA limit of 40 mcg. The capsule 'Vitamin E softgel capsule' used wheat germ oil instead of Vitamin E, misleading consumers regarding the product name. Additionally, INS food additive numbers were not specified, nor were the Vitamin E limits defined in the Nutraceuticals and New Products (Ni) table.

The 'Superbiotic capsules' contained unresolved and pathogenic strains such as Lactobacillus sporogenes, Streptococcus faecalis, Clostridium butyricum, and Bacillus mesentericus.

Ambico Ayurvedic Healthcare was cited for 'using expired materials or ingredients in the preparation of nutraceuticals and poor sanitary and hygienic conditions at production sites.'

FSSAI reported that artificial flavorings 'Coriander' and 'Strawberry' from Vedant Remedies included the use of expired materials, and also had deficiencies in sanitation, cleaning, and inadequate production infrastructure and testing systems.

Similar stories

RBI confirms listing requirement for Tata Sons and demands compliance with norms
Read more
business-standard.com

RBI confirms listing requirement for Tata Sons and demands compliance with norms

The Reserve Bank of India (RBI) reiterated the requirement for Tata Sons to comply with all regulatory norms applicable to Non-Banking Financial Companies - Upper Level (NBFC-UL), including mandatory stock market listing. This was stated in a communication addressed to the Tata Group's holding company on November 16.

In the letter sent to the CFO of Tata Sons, the central bank referred to the company's request dated October 6, in which Tata Sons sought clarification on regulatory requirements. RBI noted that although Tata Sons did not ask for clarification on any specific norm or guideline, its request seemingly related to discussions held at the company's board meeting regarding listing.

Requirement to Comply with NBFC Upper Level Norms

The letter explicitly stated: 'In this regard, you are advised to comply with all applicable rules/guidelines/directions issued by RBI concerning NBFC Upper Level (NBFC-UL), as provided for in the prevailing provisions/guidelines/directions published on the RBI website, including the requirement for your company to be listed.'

The latest communication strengthens the regulator's stance regarding Tata Sons' listing, which remains unlisted despite the established deadline of September 30, 2025, for NBFC upper level entities. This development is particularly significant ahead of the Tata Sons board meeting scheduled for November 26.

The November 16 letter followed RBI's decision on September 11 to reject Tata Sons' application for voluntary deregistration as a Company of Interest (CIC). This rejection effectively closed the company's main regulatory path to exit the NBFC structure and avoid the listing requirement.

Previously, in March 2024, Tata Sons had approached the RBI requesting deregistration after repaying all its debts. The company aimed to exit the regulatory system applicable to NBFC upper level, which would allow it to remain private. However, RBI rejected this application after examining various aspects of the request and subsequently directed the company to comply with the norms applicable to NBFC upper level.

Tata Sons was first classified as an NBFC upper level entity in September 2022 under the RBI's scale-based regulatory system. Entities categorized in this group are subject to enhanced regulatory requirements, including mandatory listing within three years of classification.

Under the revised system, NBFCs with assets of ₹1 trillion or more qualify for upper level status. As of March 31, 2026, Tata Sons reported total assets of approximately ₹2.01 trillion, significantly exceeding the set threshold.

RBI also included Tata Sons in its list of NBFC upper level entities for 2026–27, published in August, clarifying that this inclusion does not affect the outcome of the company's deregistration application, which was being considered at that time.

Tata Trusts, which collectively control about 66 percent of Tata Sons, advocate for keeping the holding company in private status. On the other hand, the Shapoorji Pallonji group, which owns approximately 18.37 percent, supports listing as a potential way to unlock the value of their investment and facilitate fundraising against their stake.

Botswana President calls for greater trade among African nations to reduce external vulnerability
Read more
noticiasaominuto.com

Botswana President calls for greater trade among African nations to reduce external vulnerability

During a state visit to Côte d'Ivoire, the President of Botswana, Duma Boko, called on African countries to intensify mutual trade. According to Boko, this greater trade integration would help the continent become less susceptible to external shocks.

Botswana, recognized as a significant diamond producer, was the guest of honor at the Sirexe 2026 international fair, which will take place in Abidjan, the economic capital of Côte d'Ivoire, between November 18 and 22. In a press conference held with his counterpart from Côte d'Ivoire, Alassane Ouattara, Boko classified the need to solve the problem of low intra-African trade volume as urgent.

Boko emphasized the importance of eliminating any obstacles hindering trade and avoiding unnecessary barriers, considering the continent's vast raw material wealth and population dynamism. He warned that such a measure would provide considerable immunity against external shocks, citing examples such as the closure of the Strait of Hormuz or the conflict between Ukraine and Russia.

Although the African Continental Free Trade Area (AfCFTA) was officially implemented in 2021, it is still far from achieving its goal of a fully integrated Africa, where the free movement of goods and people is facilitated across the region.

During this official visit, Botswana and Côte d'Ivoire signed several agreements, especially in the mining sector. President Ouattara requested private investment from Botswana in this sector, to which Boko responded that Botswana would contribute its expertise in extraction and its competence in mineral resource management.

The President of Botswana, whose economy heavily depends on diamond production—accounting for 30% of GDP and 80% of exports, according to International Monetary Fund (IMF) data—also urged African countries to better document the origin of their raw materials. He explained that current diamond buyers seek to know the story behind the product, including who the people involved are and how the item contributes to the well-being of its origin.

Côte d'Ivoire, a major agricultural producer of cocoa and cashew nuts, has experienced remarkable growth in its extractive industry in recent years, driven by the discovery of oil, gas, coltan, gold, and manganese.

Popular